Impact of Digestive Inflammatory Environment and Genipin Crosslinking on Immunomodulatory Capacity of Injectable Musculoskeletal Tissue Scaffold
Open Access
- 24 January 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (3), 1134
- https://doi.org/10.3390/ijms22031134
Abstract
The paracrine and autocrine processes of the host response play an integral role in the success of scaffold-based tissue regeneration. Recently, the immunomodulatory scaffolds have received huge attention for modulating inflammation around the host tissue through releasing anti-inflammatory cytokine. However, controlling the inflammation and providing a sustained release of anti-inflammatory cytokine from the scaffold in the digestive inflammatory environment are predicated upon a comprehensive understanding of three fundamental questions. (1) How does the release rate of cytokine from the scaffold change in the digestive inflammatory environment? (2) Can we prevent the premature scaffold degradation and burst release of the loaded cytokine in the digestive inflammatory environment? (3) How does the scaffold degradation prevention technique affect the immunomodulatory capacity of the scaffold? This study investigated the impacts of the digestive inflammatory environment on scaffold degradation and how pre-mature degradation can be prevented using genipin crosslinking and how genipin crosslinking affects the interleukin-4 (IL-4) release from the scaffold and differentiation of naïve macrophages (M0). Our results demonstrated that the digestive inflammatory environment (DIE) attenuates protein retention within the scaffold. Over 14 days, the encapsulated protein released 46% more in DIE than in phosphate buffer saline (PBS), which was improved through genipin crosslinking. We have identified the 0.5 (w/v) genipin concentration as an optimal concentration for improved IL-4 released from the scaffold, cell viability, mechanical strength, and scaffold porosity, and immunomodulation studies. The IL-4 released from the injectable scaffold could differentiate naïve macrophages to an anti-inflammatory (M2) lineage; however, upon genipin crosslinking, the immunomodulatory capacity of the scaffold diminished significantly, and pro-inflammatory markers were expressed dominantly.Keywords
This publication has 106 references indexed in Scilit:
- Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophagesExperimental & Molecular Medicine, 2014
- Structural Basis for Activity Regulation and Substrate Preference of Clostridial Collagenases G, H, and TPublished by Elsevier BV ,2013
- Serum Albumin Prevents Protein Aggregation and Amyloid Formation and Retains Chaperone-like Activity in the Presence of Physiological LigandsJournal of Biological Chemistry, 2012
- The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrumImmunology, 2011
- The requirement of zinc and calcium ions for functional MMP activity in demineralized dentin matricesDental Materials, 2010
- The extracellular matrix in development and morphogenesis: A dynamic viewDevelopmental Biology, 2010
- Inhibitory Potencies of Several Iridoids on Cyclooxygenase-1, Cyclooxygnase-2 Enzymes Activities, Tumor Necrosis Factor-α and Nitric Oxide ProductionIn VitroEvidence-Based Complementary and Alternative Medicine, 2010
- Anti-inflammatory management for tendon injuries - friends or foes?BMC Sports Science, Medicine and Rehabilitation, 2009
- In vitro, but not in vivo, reversibility of peritoneal macrophages activation during experimental acute pancreatitisBMC Immunology, 2009
- Alternative activation of macrophagesNature Reviews Immunology, 2003